Sooji Kim, DPM
Foot Surgery · New York, NYNPI 1053717629
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,602 of the $2,952 with a category attached, or 88.1%. It is spread thinly across 27 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $662 and has fallen 57.4% since, to $282 in 2025.
Across 128 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$465
- Medimetriks Pharmaceuticals, Inc.$350
- Paratek Pharmaceuticals, Inc.$334
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$294
- Treace Medical Concepts, Inc.$258
- Sebela Pharmaceuticals Inc.$171
- plus $1K from 21 others
What the payments were for
- Consulting fees$35012%
- Food & beverage$2,60288%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 42 | $465 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $350 |
| Paratek Pharmaceuticals, Inc. | 18 | $334 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 15 | $294 |
| Treace Medical Concepts, Inc. | 5 | $258 |
| Sebela Pharmaceuticals Inc. | 7 | $171 |
| Orthofix Medical, Inc. | 4 | $149 |
| Curonix LLC | 1 | $144 |
| Glenmark Therapeutics Inc. | 9 | $136 |
| Kowa Pharmaceuticals America, Inc. | 5 | $86 |
| Integra Lifesciences Corporation | 2 | $86 |
| Zimmer Biomet | 2 | $79 |
| Crossroads Extremity Systems, LLC | 1 | $68 |
| Medtronic | 2 | $61 |
| Zimvie Inc. | 1 | $31 |
| Nevro Corp. | 2 | $27 |
| Melinta Therapeutics, LLC | 1 | $27 |
| Aroa Biosurgery Incorporated | 1 | $22 |
| Bioventus LLC | 1 | $22 |
| Sanara Medtech Inc. | 1 | $21 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Arthrosurface Incorporated | 1 | $17 |
| Journey Medical Corporation | 1 | $17 |
| Dynasplint Systems Inc. | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,952 in reported general payments places this provider in the 80th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 19 | $869 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in New York
- Rick DelmonteNew York$21K
- Fabienne RottenbergNew York$12K
- Bryan MarkinsonNew York$8K
- Josef GeldwertNew York$5K
- Jacqueline SuteraNew York$5K
- Katherine LaiNew York$5K
- John JurcisinNew York$5K
- Roxann ClarkeNew York$4K
- Paul GreenbergNew York$4K
- Nancy ArtisNew York$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.